April 9th, 2020
Injections to become pills, in vision of Harvard-launched startup
New formulations enable oral delivery of therapeutics traditionally delivered intravenously
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Blavatnik Biomedical Accelerator
December 6th, 2019
Empowering mucosal healing with an engineered probiotic
Genetically programmed, living hydrogel material facilitates intestinal wound healing and may lead to a therapy for patients with inflammatory bowel disease
August 8th, 2019
Decoding touch
Accelerator-funded research points to potential therapy for heightened touch sensitivity in autism spectrum disorders
April 18th, 2019
Startup launches to tackle cough, itch, pain
Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons
March 26th, 2019
Harvard researchers’ immune-silent stem cell technology licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease
